Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vortmeyer, A. O.
Right arrow Articles by Zhuang, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vortmeyer, A. O.
Right arrow Articles by Zhuang, Z.
[Cancer Research 60, 5963-5965, November 1, 2000]
© 2000 American Association for Cancer Research


Advances in Brief

Somatic von Hippel-Lindau Gene Mutations Detected in Sporadic Endolymphatic Sac Tumors1

Alexander O. Vortmeyer2, Steve C. Huang, Christian A. Koch, Lance Governale, Rob D. Dickerman, Paul E. McKeever, Edward H. Oldfield and Zhengping Zhuang

Molecular Pathogenesis Unit [A. O. V., S. C. H., C. A. K., L. G., R. D. D., E. H. O., Z. Z.], National Institute of Neurological Disorders and Stroke, Bethesda, Maryland 20892, and Department of Pathology [P. E. M.], University of Michigan Hospitals, Ann Arbor, Michigan 48109

Endolymphatic sac tumors (ELSTs) occur sporadically or in association with an autosomal dominantly inherited tumor syndrome, von Hippel-Lindau (VHL) disease. In VHL disease, a germline mutation of the VHL tumor suppressor gene is inherited, and loss of function of the wild-type allele occurs through genetic deletion with subsequent development of neoplastic growth. Genetic alterations associated with sporadic ELSTs are less well understood. In this study, we used tissue microdissection to selectively analyze neoplastic cells from four sporadic ELSTs. In two cases, we detected somatic mutations involving VHL gene exons 1 and 2, respectively. Additionally, one of these cases revealed deletion of the VHL gene locus. Two cases did not reveal VHL gene mutation; one of these two cases showed VHL gene deletion. These results suggest that mutations and allelic deletions of the VHL tumor suppressor gene play a role in the tumorigenesis of sporadic ELSTs.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Glasker, R. R. Lonser, M. G.B. Tran, B. Ikejiri, J. A. Butman, W. Zeng, P. H. Maxwell, Z. Zhuang, E. H. Oldfield, and A. O. Vortmeyer
Effects of VHL Deficiency on Endolymphatic Duct and Sac
Cancer Res., December 1, 2005; 65(23): 10847 - 10853.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J C C Rocha, R L A Silva, B B Mendonca, S Marui, A J G Simpson, and A A Camargo
High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil
J. Med. Genet., March 1, 2003; 40(3): e31 - 31.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.